ChyloMetis
ChyloMetis is a bio-pharmaceutical company that is developing novel, first-in-class, non-immunosuppressive therapies to treat chronic gastrointestinal conditions, such as Crohn’s Disease and Irritable Bowel Disease.
Active Portfolio Company